2-Arachidonoylglycerol is an endogenous ligand for the cannabinoid receptors. Two types of cannabinoid receptors have been identified to date. The CB1 receptor is abundantly expressed in the brain, and assumed to be involved in the attenuation of neurotransmission. On the other hand, the physiological roles of the CB2 receptor, mainly expressed in several types of inflammatory cells and immunocompetent cells, have not yet been fully elucidated. In this study, we investigated possible pathophysiological roles of the CB2 receptor and 2-arachidonoylglycerol in acute inflammation in mouse ear induced by the topical application of 12-O-tetradecanoylphorbol-13-acetate. We found that the amount of 2-arachidonoylglycerol was markedly augmented in inflamed mouse ear. In contrast, the amount of anandamide, another endogenous cannabinoid receptor ligand, did not change markedly. Importantly, 12-O-tetradecanoylphorbol-13-acetate-induced ear swelling was blocked by treatment with SR144528, a CB2 receptor antagonist, suggesting that the CB2 receptor is involved in the swelling. On the other hand, the application of AM251, a CB1 receptor antagonist, exerted only a weak suppressive effect. The application of SR144528 also reduced the 12-O-tetradecanoylphorbol-13-acetate-induced production of leukotriene B 4 and the infiltration of neutrophils in the mouse ear. Interestingly, the application of 2-arachidonoylglycerol to the mouse ear evoked swelling, which was abolished by treatment with SR144528. Nitric oxide was suggested to be involved in the ear swelling induced by 2-arachidonoylglycerol. These results suggest that the CB2 receptor and 2-arachidonoylglycerol play crucial stimulative roles during the course of inflammatory reactions. ⌬ 9 -Tetrahydrocannabinol (⌬ 9 -THC), 1 a major psychoactive ingredient of marijuana, is known to bind to specific binding sites, that is, the cannabinoid receptors, thereby eliciting diverse pharmacological responses. To date, two types of cannabinoid receptor (CB1 and CB2) gene have been cloned. The CB1 receptor is expressed abundantly in the nervous tissues and the CB2 receptor is expressed primarily in the lymphoid tissues. The CB1 receptor is expressed mainly in the presynaptic terminals and is assumed to play an important role in the regulation of synaptic transmission (1, 2). On the other hand, the physiological significance of the CB2 receptor is not yet fully elucidated.
⌬
9 -Tetrahydrocannabinol (⌬ 9 -THC), 1 a major psychoactive ingredient of marijuana, is known to bind to specific binding sites, that is, the cannabinoid receptors, thereby eliciting diverse pharmacological responses. To date, two types of cannabinoid receptor (CB1 and CB2) gene have been cloned. The CB1 receptor is expressed abundantly in the nervous tissues and the CB2 receptor is expressed primarily in the lymphoid tissues. The CB1 receptor is expressed mainly in the presynaptic terminals and is assumed to play an important role in the regulation of synaptic transmission (1, 2) . On the other hand, the physiological significance of the CB2 receptor is not yet fully elucidated.
Two arachidonic acid-containing molecules have thus far been identified as endogenous ligands for the cannabinoid receptors: N-arachidonoylethanolamine (anandamide) was isolated from pig brain (3) and 2-arachidonoylglycerol (2-AG) was isolated from rat brain (4) and canine gut (5) . A number of studies have been carried out on endogenous cannabinoid receptor ligands, especially anandamide. Anandamide has been shown to exhibit a variety of cannabimimetic activities (6 -9) . With the remarkable attention directed toward anandamide in recent years, it is becoming evident that anandamide acts as a partial agonist of the cannabinoid receptors in many cases (10 -20) . In addition, tissue levels of anandamide were usually very low (in the order of picomole/g of tissue) (21, 22) . It is thus rather questionable that anandamide actually acts as an endogenous cannabinoid receptor ligand of great physiological significance in vivo (21, 23) . In contrast to anandamide, 2-AG was found to act as a full agonist in various assay systems. In fact, 2-AG is the most efficacious agonist among various 2-AG and anandamide analogs (12, 13, 15, 16, 18 -21, 23) . Furthermore, the tissue levels of 2-AG are usually several 10 to several hundred times higher than those of anandamide (21, 23) , and there is growing evidence that 2-AG can be rapidly formed from arachidonic acid-containing phospholipids upon stimulation (24 -28) . Based on these observations, we proposed that 2-AG rather than anandamide is the true natural ligand for the cannabinoid receptors (13, 15, 16, 21, 23) .
We further examined the effects of 2-AG on HL-60 cells, which express the CB2 receptor. We found that 2-AG induces the activation of p42/44 mitogen-activated protein kinase (MAP kinase) (29, 30) , the augmented production of chemokines such as IL-8 in HL-60 cells (31) and the migration of HL-60 cells that have been differentiated into macrophage-like cells (32) . Several investigators have also demonstrated that 2-AG induces the migration of mouse splenocytes (33) and microglia cells (34) through CB2 receptor-dependent mechanisms. These results suggest that 2-AG and the CB2 receptor play stimulative roles rather than suppressive roles in inflammatory reactions and immune responses. On the other hand, several investigators reported certain suppressive effects of 2-AG. For example, 2-AG induced suppression or potentiation of lymphocyte proliferation (35) , reduced expression of the IL-2 gene in murine T lymphocytes (36) , inhibition of the production of IL-6 in J774 macrophage-like cells (37) , and the inhibition of tumor necrosis factor ␣ production in lipopolysaccharide-stimulated mouse macrophages (38) , although it is not clear whether the effects of 2-AG are actually mediated through the CB2 receptor in some cases. The CB2 receptor is abundantly expressed in several types of inflammatory cells and immunocompetent cells (39 -41) ; it is essential to clarify whether the CB2 receptor and its endogenous ligand 2-AG stimulate inflammation or, on the contrary, suppress inflammatory reactions.
In the present study, we investigated in detail the possible pathophysiological roles of the CB2 receptor and 2-AG in acute inflammation in the mouse ear induced by the application of 12-O-tetradecanoylphorbol 13-acetate (TPA). We found that the amount of 2-AG in the mouse ear markedly increased following the topical application of TPA. Notably, treatment of the ear with SR144528, a CB2 receptor antagonist, blocked the ear swelling induced by TPA. Moreover, the application of 2-AG induced ear swelling that was also blocked by treatment with SR144528. These results strongly suggest that the CB2 receptor and 2-AG play crucial stimulative roles during the course of inflammatory reactions. ]dec-9-yl dithiocarbonate) and essentially fatty acid-free bovine serum albumin were purchased from Sigma. TPA, 1-anthroyl cyanide, butylated hydroxytoluene, hydrocortisone acetate, propranolol hydrochloride, N G -monomethyl-L-arginine monoacetate (L-NMMA), 7-nitroindazole, U0126, and Fura-2/AM were obtained from Wako Pure Chemical Industries (Osaka, Japan). Quinuclidine was from Molecular Probes (Eugene, OR). RHC-80267, SR141716A, and U73122 were obtained from Biomol (Plymouth Meeting, PA). SR144528 was a generous gift from Sanofi (Montpellier, France). AM251 was purchased from Tocris (Bristol, UK). 1,3-Benzylideneglycerol was synthesized from glycerol and benzaldehyde. 2-AG and 2-heptadecanoylglycerol were prepared from 1,3-benzylideneglycerol and arachidonic anhydride or heptadecanoic anhydride as described earlier (15) . An ether-linked, non-hydrolyzable analog of 2-AG (2-eicosa-5Ј,8Ј,11Ј,14Ј-tetraenylglycerol) (2-AG ether) was synthesized from 1,3-benzylideneglycerol and eicosatetraenyl iodide as previously described (15) . Anandamide and N-heptadecanoylethanolamine were prepared from ethanolamine and arachidonoyl chloride and heptadecanoyl chloride, respectively, by the method of Devane et al. (3) . Anti-phospho-p42/44 MAP kinase rabbit antibody, anti-p42/44 MAP kinase rabbit antibody, anti-phospho-p38 MAP kinase rabbit antibody, anti-p38 MAP kinase rabbit antibody, anti-phospho-c-Jun N-terminal kinase (JNK) rabbit antibody, anti-JNK rabbit antibody, anti-phospho-Akt rabbit antibody, anti-Akt rabbit antibody, and anti-rabbit IgG horseradish peroxidase-linked goat antibody were obtained from Cell Signaling Technology (Beverly, MA).
EXPERIMENTAL PROCEDURES

Chemicals-Arachidonic
Animals-Male ICR mice (body weight, 30 g) were obtained from Sankyo Labo Service (Tokyo, Japan).
Cells-Human promyelocytic leukemia HL-60 cells were grown at 37°C in RPMI 1640 medium (Asahi Technoglass Co., Chiba, Japan) supplemented with 10% fetal bovine serum in an atmosphere of 95% air and 5% CO 2 .
TPA-induced Acute Inflammation in Mouse Ear-Acute inflammation was evoked by the local application of TPA (0.8 g) dissolved in 20 l of acetone on the inner and outer surface of the right ear of ICR mice. Control mice received the vehicle (acetone) on their right ear. Ear thickness was measured using a micrometer.
Lipid Extraction from TPA-treated Mouse Ear-Mice were anesthetized with diethyl ether. TPA (0.8 g) dissolved in 20 l of acetone was then topically applied to the right ear. The vehicle (acetone) was applied to the right ear of control mice. After 4 h, the mice were anesthetized with diethyl ether and killed by bleeding from the carotidal artery. The ears were then dissected and immediately frozen in liquid nitrogen. They were then homogenized in Bligh and Dyer extraction mixture (42) using a Polytron homogenizer (Kinematica, Switzerland). Total lipid was extracted by the method of Bligh and Dyer (42) . Butylated hydroxytoluene (final concentration, 0.001%, w/v) was added to avoid lipid peroxidation. Lipid phosphorus was determined by the method of Rouser et al. (43) .
Estimation of the Amounts of Individual Molecular Species of Monoacylglycerols and N-Acylethanolamines in Mouse
Ear-For the analysis of monoacylglycerols, 2-heptadecanoylglycerol (0.1 nmol) was added as an internal standard. Total lipids were fractionated by TLC with development using petroleum ether:diethyl ether:acetic acid (20:80:1, v/v) in a tank sealed with N 2 gas. The area corresponding to the standard monoacylglycerol was scraped off the TLC plate, and extracted from silica gel by the method of Bligh and Dyer (42) . The extraction was conducted in the presence of butylated hydroxytoluene (0.001%, w/v) in a N 2 gas-sealed tube. The purified monoacylglycerols were converted to their 1-anthroyl derivatives and then analyzed with an HPLC system equipped with a reverse phase column (CAPCELL PAK C18 SG120, 4.6 ϫ 250 mm, Shiseido Co., Tokyo, Japan) and a fluorescence detector (excitation at 370 nm; emission at 470 nm). The mobile phase was acetonitrile:2-propanol:water (90:4:6, v/v), and the flow rate was 1.4 ml/min as previously described (44) . For the analysis of N-acylethanolamines, N-heptadecanoylethanolamine (0.1 nmol) was added as an internal standard. Total lipids were fractionated by TLC using development with chloroform:methanol:NH 4 OH (80:20:2, v/v) in a tank sealed with N 2 gas. The area corresponding to the standard N-acylethanolamine was scraped off the TLC plate, and extracted from the silica gel by the method of Bligh and Dyer (42) . The extraction was conducted in the presence of butylated hydroxytoluene (0.001%, w/v) in a N 2 gas-sealed tube. The N-acylethanolamine was further purified by TLC with petroleum ether:diethyl ether:acetone:acetic acid (30:40:20:1, v/v) and by subsequent TLC with an organic layer of ethyl acetate:petroleum ether:diethyl ether:acetic acid:water (100:50:20:100, v/v). N-Acylethanolamines were converted to their 1-anthroyl derivatives and then analyzed with an HPLC system equipped with a reverse phase column (CAPCELL PAK C18 SG120, 4.6 mm ϫ 250 mm ϫ 2, Shiseido Co.) and a fluorescence detector (excitation at 370 nm; emission at 470 nm). The mobile phase was acetonitrile:2-propanol:water (80:3:17, v/v), and the flow rate was 1.4 ml/min, as previously described (44) . The amounts of monoacylglycerols and N-acylethanolamines were expressed as picomole/mol of lipid phosphorus.
Effects of Cannabinoid Receptor Antagonists, ⌬ 9 -THC, Hydrocortisone, Several Enzyme Inhibitors on TPA-induced Ear Swelling-TPA (0.8 g) dissolved in 20 l of acetone was topically applied to the right ear of an ICR mouse. Control mice received the vehicle (acetone) alone. SR144528 (a CB2 receptor antagonist), AM251 (a CB1 receptor antagonist), ⌬ 9 -THC (30 g each), or several enzyme inhibitors dissolved in 20 l of acetone were then applied to the same ear. In some experiments, various concentrations of SR144528, AM251, ⌬ 9 -THC, or hydrocortisone acetate were applied to the mouse ear immediately after the application of TPA. Ear thickness was measured using a micrometer.
Effects of the Topical Application of 2-AG, 2-AG Ether, and Anandamide to Mouse Ear-2-AG, 2-AG ether, or anandamide (100 g each) dissolved in 20 l of acetone was topically applied to the right ear of an ICR mouse. Control mice received the vehicle (acetone) alone. SR144528, AM251 (100 g each), or several enzyme inhibitors dissolved in 20 l of acetone were then applied to the same ear. Ear thickness was measured using a micrometer.
Estimation of the Amount of Leukotriene B 4 (LTB 4 ) in Mouse EarThe right ear of a TPA-treated mouse or vehicle (acetone)-treated mouse was dissected, frozen in liquid nitrogen, and homogenized in 5 ml of ethanol, 1 ml of water, and 250 l of 1 M acetate buffer (pH 4.0). After standing at 4°C for 1 h, the homogenate was centrifuged at 3,000 ϫ g for 10 min at 4°C to remove precipitated proteins. The supernatant was concentrated under a gentle stream of nitrogen to 1 ml. After the addition of 5 ml of 1 M acetate buffer (pH 4.0), the sample was applied to a Waters Sep-Pak® cartridge prepared by rinsing with 3 ml of methanol followed by 3 ml of water. Following washing of the cartridge with 3 ml of water and 3 ml of n-hexane, LTB 4 was eluted with 3 ml of ethanol. The amount of LTB 4 was estimated using an LTB 4 EIA kit (520111, Cayman Chemicals, Ann Arbor, MI).
Measurement of Myeloperoxidase Activity in Mouse Ear-Myeloperoxidase (MPO), located in the azurophilic granules of neutrophils, has been used as an enzyme marker of neutrophil infiltration into inflamed tissues (45) . MPO activity in the mouse ear was estimated as described in Ref. 45 . In brief, the right ear of a TPA-treated mouse or vehicle (acetone)-treated mouse was dissected, frozen in liquid nitrogen, and homogenized in 2 ml of 50 mM potassium phosphate buffer (pH 6.0) containing 0.5% hexadecyltrimethylammonium bromide, and centrifuged at 15,000 ϫ g for 20 min to collect supernatants to be used in subsequent MPO assays. The enzyme reaction of MPO was initiated by the addition of 100 l of the assay buffer containing 3,3Ј,5,5Ј-tetramethylbenzenidine and a liquid substrate system (Sigma) to 10 l of the sample in a 96-well plate. After standing at room temperature for 30 min, the reaction was stopped by the addition of 50 l of 0.5 M H 2 SO 4 , and the absorbance at 450 nm was read using a microplate reader. ] i was estimated using a CAF-100 Ca 2ϩ analyzer (JASCO, Tokyo, Japan) as described previously (12, 13, 15, 16) . CaCl 2 was added 4 -5 min before measurement (final Ca 2ϩ concentration in the cuvette, 1 mM). 2-AG, ⌬ 9 -THC, SR144528, and AM251 were dissolved in dimethyl sulfoxide (Me 2 SO), and aliquots (1 l each) were added to the cuvette (final concentration of Me 2 SO, 0.4%, v/v). Me 2 SO (0.4%, v/v) per se did not markedly affect the [Ca 2ϩ ] i . Western Blot Analysis-The ear biopsies were frozen in liquid nitrogen and homogenized in 2 ml of ice-cold lysis buffer containing 20 mM HEPES (pH 7.3), 1% Triton X-100, 10% glycerol, 1 mM EDTA, 50 mM sodium fluoride, 2.5 mM p-nitrophenyl phosphate, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, and 10 g/ml of leupeptin. The homogenate was centrifuged at 15,000 ϫ g for 20 min, and the supernatant was aspirated into another tube. The total protein concentration was assessed using a BCA protein assay reagent (Pierce, Rockford, IL). Protein extracts (20 g) were fractionated by SDS-PAGE on 10% gels and transferred to nitrocellulose membranes. The membranes were blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.05% Tween 20 (TBST) for 1 h at room temperature. They were then incubated overnight with anti-p42/44 MAP kinase antibody (1:4,000), anti-p38 MAP kinase antibody (1:2,000), anti-JNK antibody (1:2,000), or anti-Akt antibody (1:4,000) in Tris-buffered saline (TBS) containing 5% bovine serum albumin at 4°C. The membranes were washed with TBST and incubated with the anti-rabbit IgG horseradish peroxidaselinked antibody (1:2,000) in TBST containing 5% nonfat dry milk for 1 h at room temperature. After a further washing, the membranes were analyzed with the ECL reagent. Western blot analysis of the phosphorylated protein kinases was carried out as follows. The membranes were incubated in stripping buffer composed of 62.5 mM Tris-HCl (pH 6.7), 2% SDS, and 100 mM 2-mercaptoethanol at 50°C for 40 min to strip the used antibody off the membranes. After incubation, the membranes were blocked with blocking solution, and then an immunoblot reaction was performed using the primary antibody, anti-phosphop42/44 MAP kinase antibody (1:4,000), anti-phospho-p38 MAP kinase antibody (1:2,000), anti-phospho-JNK antibody (1:2,000), or anti-phospho-Akt antibody, (1:4,000 dilution), followed by the secondary antibody, anti-rabbit IgG antibody (1:2,000).
Measurement of Intracellular Free Ca 2ϩ Concentrations ([Ca 2ϩ ] i )-
Statistical Analysis-Statistical analysis was performed using Student's t test (Figs. 2 
RESULTS
Effects of the Topical Application of TPA to Mouse Ear on the Thickness, Phospholipid Content, and Level of 2-AG-
The topical application of TPA-induced acute inflammation in the mouse ear. Ear thickness increased by 1.7-fold over the control level at 4 h (Fig. 1A) . On the other hand, the phospholipid content did not change markedly at least up to 4 h under the present experimental conditions (Fig. 1B) , suggesting that the increase in ear thickness is mainly because of edema. We then examined the effect of TPA treatment on the level of 2-AG in the mouse ear. As demonstrated in Fig. 1C , the amount of 2-AG was markedly augmented following the topical application of TPA. The amount of 2-AG in the vehicle (acetone)-treated control mouse ear was 4.2 Ϯ 2.0 pmol/mol of lipid P and in the TPA-treated mouse ear 14.4 Ϯ 2.0 pmol/mol of lipid P.
Effects of TPA Treatment on the Amounts of Individual Molecular Species of Monoacylglycerols in Mouse
Ear-We then examined the effects of TPA treatment on the amounts of various molecular species of monoacylglycerols in the mouse ear. As illustrated in Fig. 2 , the control mouse ear (treated with the vehicle alone) was found to contain various molecular species of monoacylglycerols (total 283.45 pmol/mol of lipid P): the major species were 1(3)-palmitoylglycerol plus 1(3)-oleoylglycerol plus 1(3)-cis-vaccenoylglycerol (36.7%), 2-palmitoylglycerol plus 2-oleoylglycerol plus 2-cis-vaccenoylglycerol (12.9%), and 1(3)-stearoylglycerol (34.5%). Several minor species were also found to occur, such as 1(3)-linoleoylglycerol (4.8%), 2-linoleoylglycerol (3.3%), 1(3)-AG (0.8%), and 2-AG (1.6%). Notably, TPA treatment induced severalfold increases in the levels of various 2-monoacylglycerols, that is, 2-palmitoylglycerol plus 2-oleoylglycerol plus 2-cis-vaccenoylglycerol and 2-linoleoylglycerol as well as 2-AG (Fig. 2, B, F, and H) . The level of stimulation for 2-linoleoylglycerol (3.2-fold) was almost the same as that for 2-AG (3.0-fold). On the other hand, the levels of various 1(3)-monoacylglycerols were not markedly affected by TPA treatment (Fig. 2, A, C, and E) .
Effects of TPA Treatment on the Amounts of Individual Molecular Species of N-Acylethanolamines-The effects of TPA treatment on the amounts of various molecular species of Nacylethanolamines were examined next. As shown in Fig. 3 , various species of N-acylethanolamines were found to be present in the control mouse ear (treated with the vehicle alone) (total 536.12 pmol/mol of lipid P): the major species were N-palmitoylethanolamine (56.7%), N-stearoylethanolamine (15.2%), N-oleoylethanolamine (16.2%), and N-cis-vaccenoylethanolamine (7.5%). There were several minor species such as N-myristoylethanolamine (1.3%), N-palmitoleoylethanolamine (0.9%), N-linoleoylethanolamine (1.8%), and N- FIG. 1 . Effects of the topical application of TPA to mouse ear on the thickness, phospholipid content and amount of 2-AG. A, the effect of TPA treatment (0.8 g/ear) on ear thickness was determined using a micrometer as described under "Experimental Procedures." B, the effect of TPA treatment (0.8 g/ear) on the phospholipid content in the mouse ear was estimated by measuring lipid phosphorus as described under "Experimental Procedures." C, the effect of TPA treatment (0.8 g/ear) on the amount of 2-AG in the mouse ear was estimated using reverse-phase HPLC as described under "Experimental Procedures." Open circle, control (acetone alone); closed circle, TPA. The data are the mean Ϯ S.D. of five determinations.
arachidonoylethanolamine (anandamide) (0.2%). In contrast to the case for monoacylglycerols shown in Fig. 2 , TPA treatment did not markedly affect the levels of any molecular species of N-acylethanolamines. possible close involvement of the cannabinoid receptors in TPAinduced acute inflammation. To clarify whether this is the case, we first examined the effects of SR144528, a CB2 receptor antagonist; AM251, a CB1 receptor antagonist; and ⌬ 9 -THC on TPA-induced ear swelling. Fig. 4 shows the time course of the effects of these compounds. We found that ear swelling induced by TPA was dramatically suppressed when SR144528 (30 g/ ear) was applied together with TPA ( Fig. 4A) : the inhibition was 93.7% at 4 h and 74.0% at 6 h. In contrast to SR144528, the application of AM251 (30 g/ear) to the ear exerted only a weak suppressive effect (Fig. 4B) , the inhibition being 42.7% at 4 h and 20.6% at 6 h. A similar result was observed with SR141716A, another CB1 receptor antagonist (data not shown). Interestingly, ⌬ 9 -THC (30 g/ear) reduced the ear swelling similar to SR144528 (Fig. 4C) .
Effects of Cannabinoid Receptor Antagonists and
We then examined in more detail the activities of SR144528, AM251, and ⌬ 9 -THC to suppress TPA-induced ear swelling and compared them with that of hydrocortisone. As shown in Fig.  5A , SR144528 suppressed the ear swelling induced by TPA in a dose-dependent manner: the IC 50 was 0.6 g/ear. The activity of SR144528 was calculated to be about 1/15 of that of hydrocortisone (IC 50 , 0.04 g/ear) (Fig. 5D ). ⌬ 9 -THC also exhibited appreciable activity, the IC 50 being 1.3 g/ear (Fig. 5C ). On the other hand, AM251 only modestly suppressed ear swelling; the apparent inhibition was observed only at high doses and the IC 50 was 12 g/ear (Fig. 5B) .
Inhibition by SR144528 and ⌬ 9 -THC of the Agonistic Activity of 2-AG Toward the CB2 Receptor-As demonstrated in Figs. 4 and 5, SR144528 markedly suppressed ear swelling induced by TPA, whereas AM251 had only a modest effect. This strongly suggests that the CB2 receptor rather than the CB1 receptor is involved in TPA-induced ear swelling. Inasmuch as ⌬ 9 -THC also exhibited appreciable inhibitory activity, we examined whether ⌬ 9 -THC antagonizes the action of 2-AG, like SR144528, in a CB2 receptor-dependent manner. In this experiment, we employed HL-60 cells, which are known to abundantly express the CB2 receptor but not the CB1 receptor (16) . As shown in Fig. 6 , we found that ⌬ 9 -THC (1 M) induced only a slight increase in [Ca 2ϩ ] i in HL-60 cells in comparison with 2-AG (1 M). Instead, ⌬ 9 -THC (1 M) reduced the response induced by 2-AG (1 M), similar to SR144528 (1 M). In contrast to SR144528 and ⌬ 9 -THC, AM251 did not affect the response induced by 2-AG. These results clearly indicate that ⌬ 9 -THC acts as a weak partial agonist toward the CB2 receptor and counteracts the action of 2-AG. It is possible, therefore, that the inhibitory actions of SR144528 and ⌬ 9 -THC against TPA-induced ear swelling are mainly because of interference with the functions of the CB2 receptor and its endogenous ligand 2-AG.
Effects of SR144528 on TPA-induced Generation of LTB 4 and Infiltration of Neutrophils-We next examined the effects of SR144528 on the TPA-induced generation of LTB 4 and the infiltration of neutrophils. We first examined the effect of SR144528 on TPA-induced generation of LTB 4 . As depicted in Fig. 7A , the level of LTB 4 in mouse ear was markedly elevated following the application of TPA. Notably, treatment of the ear with SR144528 (30 g/ear) blocked LTB 4 production triggered by TPA. Treatment of the ear with TPA also induced the infiltration of neutrophils that was monitored by MPO activity. The TPA-induced infiltration of neutrophils was diminished by treatment of the ear with SR144528 (30 g/ear) (Fig. 7B) . 
Effects of Ro 31-8220, RHC-80267, D609, n-Butanol, Propranolol, and U73122 on the Level of 2-AG and the Thickness of TPA-treated Mouse Ear-
We then investigated the effects of several enzyme inhibitors on the amount of 2-AG and the thickness of the TPA-treated mouse ear. We found that the topical application of Ro 31-8220 (a protein kinase C inhibitor, 50 g/ear), RHC-80267 (a diacylglycerol lipase inhibitor, 50 g/ear), D609 (a phosphatidylcholine-specific phospholipase C inhibitor, 50 g/ear), n-butanol (an inhibitor of phospholipase D-mediated formation of phosphatidic acid, 20 mg/ear), and propranolol (a phosphatidic acid phosphohydrolase inhibitor, 50 g/ear) markedly reduced the generation of 2-AG induced by TPA (Fig. 8A ). U73122 (a phosphatidylinositol-specific phospholipase C inhibitor, 50 g/ear) also reduced the generation of 2-AG induced by TPA, although its effect was less pronounced compared with the others. Notably, the thickness of the TPAtreated mouse ear was reduced following the application of Ro 31-8220, RHC-80267, D609, n-butanol, and propranolol (Fig.  8B) . A similar but less prominent suppressive effect was observed with U73122. These results suggest that: 1) protein kinase C; 2) phosphatidylcholine-specific phospholipase C and the combined actions of phospholipase D and phosphatidic acid phosphohydrolase as well as phosphatidylinositol-specific phospholipase C; and 3) diacylglycerol lipase are involved in TPA-induced 2-AG generation as well as ear swelling.
Effects of the Topical Application of 2-AG, 2-AG Ether, and Anandamide on Mouse Ear
Thickness-We next examined whether the application of 2-AG, 2-AG ether, a non-hydrolyzable analog of 2-AG, and anandamide causes ear swelling. As shown in Fig. 9A , the application of 2-AG (100 g/ear) induced ear swelling; the maximal response was observed 1 h after the application of 2-AG. Importantly, 2-AG-induced ear swelling was abolished by treatment of the ear with SR144528 (100 g/ear). On the other hand, AM251 (100 g/ear) exerted only a slight effect on 2-AG-induced ear swelling. Similar results were obtained for 2-AG ether, a non-hydrolyzable analog of 2-AG (100 g/ear) (Fig. 9B) . However, in contrast to 2-AG and 2-AG ether, anandamide did not induce ear swelling (Fig. 9C) .
Effects and Akt. Fig. 10 shows the results of Western blot analysis. We found that the topical application of 2-AG to mouse ear (100 g/ear) provoked markedly augmented phosphorylation of p42/44 MAP kinase (Fig. 10, top panel) . We also found that treatment of the ear with 2-AG evoked enhanced phosphorylation of p38 MAP kinase (Fig. 10, second panel) . On the other hand, marginal effects were observed with JNK (Fig. 10, third  panel) and Akt (Fig. 10, bottom panel) . The augmented phosphorylation of p42/44 MAP kinase and p38 MAP kinase was also observed for TPA-treated mouse ear (Figs. 10, first and   second panels) . We found that the phosphorylation of p42/44 MAP kinase and p38 MAP kinase was markedly reduced when SR144528 was applied together with 2-AG or TPA (data not shown).
Effects of L-NMMA and 7-Nitroindazole on 2-AG-and TPAinduced Ear
Swelling-Finally, we examined the effects of L-NMMA and 7-nitroindazole, nitric-oxide (NO) synthase inhibitors, on 2-AG-and TPA-induced ear swelling. As shown in Fig. 11A , the application of L-NMMA markedly reduced ear swelling induced by 2-AG (100 g/ear). L-NMMA also reduced TPA-induced ear swelling (0.8 g/ear) (Fig. 11B) . Similar results were obtained for 7-nitroindazole (Fig. 11, C and D) . These results strongly suggest that NO is closely involved in the ear swelling induced by 2-AG and TPA. DISCUSSION The CB2 receptor is abundantly expressed in several types of inflammatory cells and immunocompetent cells such as B lymphocytes, natural killer cells, and macrophages/monocytes (39 -41) . Such a distribution strongly suggests that the CB2 receptor is involved in the regulation of several inflammatory reactions and immune responses. Previously, Casellas and coworkers (46) In the present study, we examined in detail the possible involvement of the CB2 receptor and its endogenous ligand 2-AG in TPA-induced acute inflammation in mouse ear. We found that the amount of 2-AG in the mouse ear was markedly augmented following the topical application of TPA, which induces acute inflammation (Figs. 1C and 2H) . Importantly, TPA-induced ear swelling was blocked by the application of SR144528, a CB2 receptor antagonist (Figs. 4A and 5A ). On the other hand, the application of AM251, a CB1 receptor antagonist, exerted only a weak suppressive effect (Figs. 4B and 5B) . Notably, the topical application of 2-AG to mouse ear induced swelling, which was abolished by treatment of the ear with SR144528 but not with AM251 (Fig. 9A) . We obtained evidence that NO is involved in the ear swelling induced by 2-AG (Fig.  11 ). This appears to be consistent with the previous observation by others that 2-AG induces the generation of NO in certain types of cells (48, 49) . We also found that p42/44 MAP kinase and p38 MAP kinase are rapidly phosphorylated in 2-AG-and TPA-treated mouse ear (Fig. 10) . Cannabinoid receptor agonist-induced augmented phosphorylation of p42/44 MAP kinase and p38 MAP kinase has already been demonstrated by several investigators (29, 50 -52) . The exact mechanisms by which p42/44 MAP kinase and p38 MAP kinase participate in ear swelling is not yet clear. However, it is noteworthy that several investigators have reported that p42/44 MAP kinase and p38 MAP kinase take important parts in the production of NO in several types of cells (53, 54) . It is plausible, therefore, that these protein kinases are involved in the production of NO in 2-AG-and TPA-treated mouse ear as well. In fact, we found that U0126 (50 g/ear), an inhibitor of MEK that is upstream of the p42/44 MAP kinase, and SB239063 (50 g/ear), a p38 MAP kinase inhibitor, markedly suppressed 2-AG-induced ear swelling (93% inhibition and 87% FIG. 7 . Effects of SR144528 on TPA-induced generation of LTB 4 and the infiltration of neutrophils. A, the effect of SR144528 on the generation of LTB 4 in mouse ear. TPA (0.8 g) dissolved in 20 l of acetone was topically applied to a mouse ear. Control mice received the vehicle (acetone) alone. SR144528 (30 g) or the vehicle (acetone) were then applied to the same ear. Four hours after the application of TPA and SR144528, the amount of LTB 4 was estimated using an LTB 4 EIA kit as described under "Experimental Procedures." The data are the mean Ϯ S.D. from four determinations. **, p Ͻ 0.01. B, the effect of SR144528 on the infiltration of neutrophils into mouse ear. TPA (0.8 g) dissolved in 20 l of acetone was topically applied to a mouse ear. Control mice received the vehicle (acetone) alone. SR144528 (30 g) or the vehicle (acetone) were then applied to the same ear. Six hours after the application of TPA and SR144528, the infiltration of neutrophils was determined by estimating MPO activity as described under "Experimental Procedures." The data are the mean Ϯ S.D. from six determinations. **, p Ͻ 0.01.
FIG. 8. Effects of Ro 31-8220, RHC-80267, D609
, n-butanol, propranolol, and U73122 on the level of 2-AG and the thickness of the TPA-treated mouse ear. TPA (0.8 g) dissolved in 20 l of acetone was topically applied to a mouse ear. Various enzyme inhibitors (50 g for Ro 31-8220, RHC-80267, D609, propranolol, and U73122, 20 mg for n-butanol) dissolved in 20 l of acetone (except for n-butanol) were applied to the same ear. A, the effects on the TPA-induced increase in the level of 2-AG. Four hours after the application of TPA and inhibitors, the amount of 2-AG in mouse ear was estimated using reverse-phase HPLC as described under "Experimental Procedures." The data are the mean Ϯ S.D. from five to six determinations. **, p Ͻ 0.01 (compared with TPA alone). B, the effects on TPA-induced ear swelling. Four hours after the application of TPA and inhibitors, ear thickness was measured using a micrometer as described under "Experimental Procedures." The data are the mean Ϯ S.D. from six determinations. **, p Ͻ 0.01 (compared with TPA alone).
inhibition, respectively) and TPA-induced ear swelling (57% inhibition and 81% inhibition, respectively). 2 Jaffee et al. (55) also reported that U0126 reduced TPA-induced ear swelling. With respect to p38 MAP kinase, this enzyme may also be involved in the production of proinflammatory cytokines, in addition to the production of NO, as has been reported for various types of inflammatory reactions (56) . Further studies are necessary to fully elucidate the molecular mechanisms underlying 2-AG-and TPA-induced ear inflammation.
Whatever the detailed mechanism, the results of the present investigation strongly suggest that the CB2 receptor and 2-AG play crucial stimulative roles during the course of acute inflammatory reactions induced by TPA. Importantly, this appears not to be restricted to TPA-induced acute inflammation. Recently, we observed similar stimulative roles of the CB2 receptor and 2-AG in oxazolone-induced allergic inflammation in mouse ear. 2 It is possible, therefore, that the involvement of CB2 receptor and 2-AG is a common feature of diverse inflammatory reactions.
In contrast to 2-AG, the amount of anandamide, another endogenous cannabinoid receptor ligand, was not affected by the application of TPA (Fig. 3H) . Moreover, topical application of anandamide did not induce ear swelling (Fig. 9C) . Taken together, it is conceivable that anandamide is not involved in TPA-induced inflammation in the mouse ear. Previously, we found that 2-AG stimulates HL-60 cells and human monocyte functions in vitro. For example, 2-AG induces the augmented production of chemokines (31) and the migration of macrophage-like cells (32) through CB2 receptor-dependent mechanisms. Several investigators have also demonstrated that 2-AG induces the migration of mouse splenocytes (33) and microglia cells (34) . These observations are in line with those of the present investigation showing that the CB2 receptor and 2-AG play important stimulative roles in TPAinduced acute inflammation in vivo. Iwamura et al. (57) also reported that the CB2 receptor is crucially involved in carrageenan-induced rat paw edema.
On the other hand, several investigators demonstrated that cannabinoids and the CB2 receptor exert suppressive effects on inflammatory reactions and immune responses. For example, the oral administration of ⌬ 9 -THC suppressed rat paw edema induced by carrageenan (58) . In this study, we also found that topical application of ⌬ 9 -THC reduced mouse ear swelling induced by TPA (Figs. 4C and 5C ). These inhibitory effects of ⌬ 9 -THC do not appear to be in conflict with the notion that the endogenous CB2 receptor agonist, which is 2-AG, plays important stimulative roles in inflammation. We confirmed that the addition of ⌬ 9 -THC to HL-60 cells, which express mainly the CB2 receptor, markedly reduced the response induced by 2-AG similar to SR144528 (Fig. 6) . Bayewitch et al. (59) have also demonstrated that ⌬ 9 -THC acts as an antagonist toward the CB2 receptor. Taken together, it is plausible that ⌬ 9 -THC counteracts the action of 2-AG at the CB2 receptor as in the case of SR144528, thereby reducing inflammatory reactions.
As for 2-AG, several investigators have reported that it induces suppression or potentiation of lymphocyte proliferation (35) , reduced expression of the IL-2 gene in murine T lymphocytes (36) , inhibition of the production of IL-6 in J774 macrophage-like cells (37) , and the inhibition of tumor necrosis factor ␣ production in lipopolysaccharide-stimulated mouse macrophages (38) , although it is not clear in some cases whether the effects of 2-AG are actually mediated through the CB2 receptor. These results may suggest that 2-AG plays suppressive roles in inflammatory reactions and immune responses. This appears to be rather contradictory to the results of our previous studies and the present study showing that 2-AG plays stimulative roles during the course of inflammatory reactions. A possible reason for this discrepancy may be a difference in the responses and cytokines in our studies and those of other investigators. Another possibility is that the arachidonic acid and/or its metabolites that may have been formed from 2-AG are more or less implicated in the responses induced by 2-AG. To evaluate the exact biological activities of 2-AG, it is essential to minimize the effects of the metabolites of 2-AG. We confirmed that arachidonic acid did not induce the activation of p42/44 MAP kinase (29) , augment production of chemokines (31) , and migration of HL-60 cells differentiated into macrophage-like cells (32) . Concerning the effect of arachidonic acid on the mouse ear, it has been demonstrated that the application of arachidonic acid provokes ear swelling (60) . However, we found that arachidonic acid-induced ear swelling (100 g/ear) was not blocked by SR144528 (100 g/ear), 2 which is distinct from the 2-AG-induced ear swelling shown in the present study. Hence, arachidonic acid and/or its metabolites that may have been derived from 2-AG are not implicated in our cases. On the other hand, Lee et al. (35) suggested that arachidonic acid and/or its metabolites are possibly involved in 2-AG-induced modulation of lymphocyte proliferation.
There are also several reports showing that certain cannabinoid receptor agonists such as WIN55212-2 exert inhibitory effects on inflammatory reactions in vivo (61-64), although the mechanisms involved are yet to be clarified. Recently, we found that WIN55212-2 (1 M) completely blocked the 2-AG-induced migration of HL-60 cells differentiated into macrophage-like cells from the upper to lower compartment of the Transwell TM inserts when added together with 2-AG (1 M) to the lower compartment. 2 We also found that the topical application of WIN55212-2 reduced ear swelling induced by TPA and 2-AG. 2 Given that WIN55212-2 acts as a full agonist toward the CB2 receptor (16) , it is rather surprising that WIN55212-2, like SR144528, abrogated the response induced by 2-AG. A possible explanation may be that a much more prolonged anergic condition, which is attributed to desensitization and subsequent receptor internalization, occurs following stimulation with WIN55212-2 compared with the case of the stimulation with 2-AG. We confirmed that this is the case in a recent study in which we examined the restoration of HL-60 cells, which had been stimulated with 2-AG or WIN55212-2, from anergy to the condition capable of responding to 2-AG. 2 2-AG is a metabolically labile molecule, whereas WIN55212-2 is a stable molecule and, because of this, the anergic condition is sustained for a longer period. This is a possible reason why WIN55212-2 interferes with the action of 2-AG and behaves as almost an antagonist in some cases in vivo. Further studies are necessary to elucidate the exact mechanism underlying the suppression of inflammation induced by a cannabinoid receptor agonist such as WIN55212-2.
A striking observation in this study is that not only 2-AG but also several other species of 2-monoacylglycerol were generated in the mouse ear following TPA treatment (Fig. 2) . The physiological meaning of the generation of 2-monoacylglycerol, other than 2-AG, in inflamed tissues is not yet clear. Ben-Shabat et al. (65) demonstrated that various 2-monoacylglycerols play a role in protecting 2-AG from enzymatic degradation. They called this an "entourage effect. " It is possible that such a protective mechanism may operate in inflamed tissues as well. Another possibility is that these 2-monoacylglycerols interact with unidentified specific binding site(s), thereby exerting some biological effect in inflamed tissues. The elucidation of whether these 2-monoacylglycerols have some particular physiological function in vivo awaits investigation.
That no preferential formation of 2-AG, among various species of 2-monoacylglycerol, was observed in the TPA-treated mouse ear provides insight into the mechanism of the generation of 2-AG. Previously, we found that the level of 2-AG was markedly elevated in picrotoxinin-administered rat brain (66) . In this case, the generation of other species of monoacylglycerol was negligible. It is apparent, therefore, that the mechanism underlying the generation of 2-AG in the brain and that in inflamed tissues are considerably different. We and several other investigators have previously pointed out that 2-AG can be formed from inositol phospholipids via the combined actions of phospholipase C and diacylglycerol lipase or the combined actions of phospholipase A 1 and phospholipase C in the brain (4, 24) . These pathways appear to favor the selective formation of 2-AG, because the fatty acyl moiety at the 2-position of inositol phospholipids is accounted for mainly by arachidonic acid. However, it seems unlikely that inositol phospholipids act as the sole source of 2-AG in inflamed tissues: the rank order of the amounts of 2-monoacylglycerol generated was 2-palmitoylglycerol plus 2-oleoylglycerol plus 2-cis-vaccenoylglycerol Ͼ 2-linoleoylglycerol Ͼ 2-AG. As shown in Fig. 8 , we found that the application of D609 (a phosphatidylcholine-specific phospholipase C inhibitor), n-butanol (an inhibitor of the phospholipase D-mediated formation of phosphatidic acid) and propranolol (a phosphatidic acid phosphohydrolase inhibitor), in addition to RHC-80267 (a diacylglycerol lipase inhibitor), sup-pressed both the generation of 2-AG and ear swelling induced by TPA. These results suggest that not only inositol phospholipids but also other phospholipids, such as phosphatidylcholine, act as the predominant sources of 2-AG in TPA-induced inflammation, although the relative importance of the biosynthetic routes responsible for the generation of diacylglycerol is yet to be determined. Interestingly, Bisogno et al. (67) reported that 2-AG is produced mainly from diacylglycerol derived from phosphatidic acid in ionomycin-stimulated N18TG2 cells. Further studies are necessary for a full understanding of the biosynthetic pathways for 2-AG in inflamed tissues.
In summary, we found that the topical application of TPA to the mouse ear induces the rapid generation of 2-AG. The application of SR144528 markedly reduced ear swelling, the generation of LTB 4 , and the infiltration of neutrophils induced by TPA. We also found that the application of 2-AG evoked ear swelling, which was blocked by treatment of the ear with SR144528. These results strongly suggest that 2-AG and the CB2 receptor are crucially involved in acute inflammations such as TPA-induced inflammation. Not much attention has thus far been directed toward 2-AG and the CB2 receptor in inflammation. Detailed studies of 2-AG and the CB2 receptor are therefore essential for a thorough elucidation of the precise regulatory mechanisms of various inflammatory reactions.
